109687 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector Special targeting system for viral vectors
Adenoviral Mediated Targeting of Activated Immune Cells
#2SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#3SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF
#4DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
#5VIRUSES WITH MODIFIED CAPSID PROTEINS
#6ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING PEPTIDYLARGININE DEIMINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE
#7Oncolytic virus expressing interferon and application therefor
#8ADENOSOMES
#9MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS
#10Recombinant adenoviruses and stem cells comprising same
#11Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#12Detargeted adenovirus variants and related methods
#13SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF
#14Methods and compositions for gene inactivation
#15Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
#16SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#17Modified serotype 28 adenoviral vectors
#18Detargeted adenovirus variants and related methods
#19Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#20Targeted adenoviruses and methods of making, isolating, and using
#21Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#22ADENOVIRAL TARGETING, COMPOSITIONS AND METHODS THEREFOR
#23mda-9/syntenin promoter to image and treat metastatic cancer cells
#24MODIFIED ADENOVIRUS HEXON PROTEIN AND USES THEREOF
#25Oncolytic adenovirus armed with therapeutic genes
#26Modified serotype 28 adenoviral vectors
#27Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#28Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#29Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#30Selective cell targeting using adenovirus and chemical dimers
#31Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#32Uniform field magnetization and targeting of therapeutic formulations
#33Methods and compositions for gene inactivation
#34Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#35Adenoviral vector-based dengue fever vaccine
#36Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
#37Compositions and methods for retargeting virus constructs
#38Hexon Tat-PTD modified adenovirus and uses thereof
#39Uniform field magnetization and targeting of therapeutic formulations
#40HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAME
#41Uniform Field Magnetization and Targeting of Therapeutic Formulations
#42Methods and compositions for gene inactivation
#43Methods and compositions for gene inactivation
#44INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#45MICROBUBBLE ASSISTED VIRAL DELIVERY
#46MULTICOMPONENT MAGNETIC NANOPARTICLE DELIVERY SYSTEM FOR LOCAL DELIVERY TO HEART VALVE LEAFLETS AND OTHER ANIMAL TISSUES
#47Intracellular viral vector delivery method employing iron ion/viral vector composite
#48Adenovirus dodecahedron particles for delivery of pharmaceutical agents
#49NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#50METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES
#51Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#52Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#53Peptides that target dorsal root ganglion neurons
#54ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLES
#55ADENOVIRUS TARGETING
#56Promoter and viral vector containing the same
#57Modulation of Adenoviral Tropism
#58ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS
#59Capsid-Incorporated Antigen for Novel Adenovirus Vaccine
#60Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#61VIRAL VECTOR SYSTEM, A COMPOSITION COMPRISING THE VIRAL VECTOR SYSTEM AND ITS USE
#62Modified viral vector particles
#63Compositions and methods for retinal transduction and photoreceptor specific transgene expression
#64TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#65Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
#66Methods and compositions for gene inactivation
#67Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
#68Serotype of adenovirus and uses thereof
#69Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
#70Inhibition of the liver tropism of adenoviral vectors
#71Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#72Oncolytic adenovirus armed with therapeutic genes
#73Metastatic colon cancer specific promoter and uses thereof
#74Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#75Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
#76Uniform field magnetization and targeting of therapeutic formulations
#77Modified Adenovirus Hexon Protein and Uses Thereof
#78Compositions and methods for generating and screening adenoviral libraries
#79Adenoviral fiber exchange shuttle system
#80Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
#81Systemic viral/ligand gene delivery system and gene therapy
#82Cancer-targeted viral vectors
#83Adenoviral vectors and uses thereof
#84VEGFR-1 TARGETING PEPTIDES
#85Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#86Serotype of adenovirus and uses thereof
#87Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#88Methods and compositions for gene inactivation
#89Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
#90SHIELDED ADENOVIRAL VECTORS AND METHODS OF USE
#91Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#92Modified virus
#93Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof
#94Targeting adenoviral vectors to dendritic cells
#95Targeted Vectors
#96Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient
#97Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
#98Use of receptor sequences for immobilizing gene vectors on surfaces
#99Serotype of adenovirus and uses thereof
#100Methods and compositions for in vivo inflammation monitoring
#101Gene transfer with adenoviruses having modified fiber proteins
#102Modified fiber proteins for efficient receptor binding
#103Adenoviral vector-based vaccines
#104Capsid-modified adenovirus vectors and methods of using the same
#105Recombinant modified adenovirus fiber protein
#106Modified adenoviral fiber with ablated to cellular receptors
#107Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#108Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
#109Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
#110Oncolytic adenovirus armed with therapeutic genes
#111Method of using adenoviral vectors with increased persistence in vivo
#112Methods and vectors for controlling gene expression
#113Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
#114Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#115Adenovirus vectors for immunotherapy
#116Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
#117Modified viral vector particles
#118Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
#119Targeted adenovirus vectors for delivery of heterologous genes
#120Cancer - targeted viral vectors
#121Vectors and methods for gene transfer
#122Serotype of adenovirus and uses thereof
#123Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#124Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#125Modified adenovirus containing a fiber replacement protein
#126Serotype of adenovirus and uses thereof
#127Biopanning and rapid analysis of selective interactive ligands (brasil)
#128Systemic viral/ligand gene delivery system and gene therapy
#129Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof
#130Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus